Pfizer, Inc. (NY:PFE)
Delayed: 29.04 -0.07 (0.24%)
Trade Now!
Previous Close $29.11    52 Week High $31.15 
Open $28.86    52 Week Low $21.40 
Day High $29.11    P/E 20.60 
Day Low $28.68    EPS $1.41 
Volume 35,082,013       

Friends, Peers and Foes (?): BMY, ZTS, MRK, JNJ, MYL (more...)

May 23, 2013 09:00 AM Lpath Initiates Dosing in First Proof-of-Concept Trial of Anti-Cancer Drug, ASONEP
May 22, 2013 05:41 PM Market Wrap: Bernanke Baffles Markets; Tesla Off the Hook; H-P Stuns Street
May 22, 2013 10:19 AM Notable Mergers and Acquisitions of the Day 05/22: (PFE)/(ZTS) (MBND) (CLWR)/(S) (GAGA)
May 22, 2013 09:53 AM Form 8-K Zoetis Inc. For: May 22
May 22, 2013 09:36 AM StreetInsider.com Pre-Open Movers 5/22: (ZLC) (SKS) (TOL) Higher; (UAN) (TGT) (SODA) Lower (more...)
May 22, 2013 08:04 AM Pfizer (PFE) to Split Off Remaining Interest in Zoetis (ZTS)
May 22, 2013 08:02 AM Zoetis To File Registration Statement; Comments on Pfizer’s Split-off Plans for Remaining Interest in Zoetis
May 22, 2013 08:01 AM Pfizer Announces Plan for Split-Off of Zoetis
May 20, 2013 05:05 PM Pfizer (PFE) Discontinues Phase 3 Study of Inotuzumab Ozogamicin
May 20, 2013 05:01 PM Pfizer Discontinues Phase 3 Study of Inotuzumab Ozogamicin in Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma (NHL) Due to Futility
View All Articles

Entities mentioned with PFE

View All Entities